1. American Academy of Ophthalmology (AAO), 2005. Preferred practice patterns: age-related macular degeneration. Prepared by the American Academy of Ophthalmology. Retina (Copyright 2005). 〈http://www.aao.org/education/guidelines/ppp/amd_new.cfm〉 purchase order number: #110078.
2. Treatment of age-related macular degeneration with photodynamic therapy study group. Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials—TAP and VIP Report No. 3;Arnold;Am. J. Ophthalmol.,2004
3. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration;Augustin;Ophthalmology,2006
4. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration;Avery;Ophthalmology,2006
5. Banker, A.S., Flores-Aguzilar, M., Arevalo, J.F., 2006. Intravitreal bevacizumab as isolated first line therapy in patients with new untreated choroidal neovascular membranes. Abstract: ASRS/EVRS Cannes Retina Festival 2006, Cannes France, September 8–13.